Harvoni median price by country 2019

Among the listed countries, the United States had by far the highest median price per monthly supply of Harvoni, a medication for hepatitis C. This statistic shows the median price of Harvoni in select developed countries, based on 2019 data.

Median price of hepatitis C drug Harvoni in select countries in 2019 (in U.S. dollars)

Characteristic	Median price in U.S. dollars
United States	30,808
Spain	18,305
Germany	16,787
Greece	15,096
Switzerland*	14,720
Chile	4,944

Loading statistic...

Download

Source

Show detailed source information?

Already a member?

Source

Use Ask Statista Research Service

Release date

July 2022

More information

Region

Worldwide

Survey time period

2019

Supplementary notes

Prices are for Harvoni (Ledipasivir 90mg/Sofosbuvir 400mg), 1 month supply.
The source compared the median prices paid by a sample of private health insurance companies for 34 specific health care services in 11 countries in 2019. Health cost comparisons among various countries are complicated by differences in sectors, fee schedules, and prices may not be representative of prices paid by other plans in that market. The limitations were minimized by selecting services with very specific definitions and wording survey questions to match the procedures that are the basis of the U.S. payment system.

* Swiss costs are list prices prior to any discount payers may receive.

Citation formats